DiaSorin S.p.A. (0GZX.IL)

87,61 +1,28 (+1,48%) Alla chiusura: 05:21PM BST

DiaSorin S.p.A.

Via Crescentino
Saluggia, VC 13040
Italy
39 01 614871
https://diasoringroup.com/en

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 3.278

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Carlo Rosa	CEO, GM & Exec. Director	1,75M	N/D	1966
Dr. Chen Menachem Even	Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Director	857,25k	N/D	1963
Mr. Piergiorgio Pedron	Sr. Corp. VP, CFO & Corp. Accounting Documents Officer	N/D	N/D	1971
Mr. Fabrizio Piercarlo Bonelli	Corp. VP & Chief Technology Officer	N/D	N/D	N/D
Dr. Riccardo Fava	Corp. VP of Communication & Investor Relations	N/D	N/D	N/D
Mr. Ulisse Spada	Corp. VP, Head of the Legal Department, Sec. & Gen. Counsel	N/D	N/D	N/D
Mr. Stefano Ronchi	Sr. Corp. VP of HR	N/D	N/D	1960
Mr. Ugo Gay	Chief Exec. Officer of DiaSorin Italia S.p.A.	N/D	N/D	1965
Mr. Angelo Rago	Pres of Luminex Corp.	N/D	N/D	1963

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Governance aziendale

L'ISS Governance QualityScore di DiaSorin S.p.A. al 1 ottobre 2023 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 9; diritti degli azionisti: 8; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.